Lerace Injection 5ml

Lerace Injection 5ml contains levetiracetam, an antiepileptic medication used for the treatment of seizures (epileptic fits). Levetiracetam works by stabilizing electrical activity in the brain, thus preventing abnormal, excessive electrical discharges that lead to seizures.

Key Ingredient:

• Levetiracetam: Levetiracetam is an antiepileptic drug that belongs to the class of medications known as pyrrolidine derivatives. It is thought to exert its antiepileptic effects by modulating neurotransmitter release, particularly the release of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), although its exact mechanism of action is not fully understood.

Uses:

Lerace Injection 5ml is indicated for the management of various types of seizures, including:

• Partial-onset seizures (also known as focal seizures) in adults and children aged 4 years and older.
• Myoclonic seizures in patients with juvenile myoclonic epilepsy.
• Primary generalized tonic-clonic seizures in adults and children aged 6 years and older.
• Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy.

Directions for Use:

• Lerace Injection is administered as an intravenous infusion (IV) under the supervision of a healthcare professional.
• The dosage and infusion rate of Lerace Injection are determined based on the patient’s age, weight, renal function, and seizure type.
• The infusion duration and rate should be adjusted according to the recommended guidelines provided by the prescribing healthcare provider.
• Lerace Injection should be diluted prior to administration using a compatible intravenous solution, such as saline or dextrose solution.
• The diluted solution should be administered slowly over a specified period to minimize the risk of adverse effects.

Precautions:

• Lerace Injection should be administered cautiously in patients with a history of psychiatric disorders or suicidal ideation, as it may exacerbate or precipitate psychiatric symptoms.
• Patients receiving Lerace Injection should be monitored closely for signs of hypersensitivity reactions, including rash, fever, and liver function abnormalities.
• Lerace Injection may cause dizziness, drowsiness, or coordination difficulties, which may impair the ability to perform tasks requiring mental alertness or physical coordination, such as driving or operating machinery.
• Lerace Injection should be used with caution in patients with impaired renal function, and dosage adjustments may be necessary based on renal function tests.
• Lerace Injection should not be abruptly discontinued without consulting a healthcare provider, as sudden withdrawal may precipitate seizures.

Frequently Asked Questions (FAQs):

1. How quickly does Lerace Injection work to control seizures? The onset of action of Lerace Injection varies depending on individual factors such as the patient’s seizure type, dosage, and response to treatment. Some patients may experience a reduction in seizure frequency shortly after starting Lerace Injection, while others may require several days or weeks to achieve optimal seizure control.
2. Can Lerace Injection be used in children? Lerace Injection is approved for use in children aged 4 years and older with certain types of seizures. The dosage and administration of Lerace Injection in pediatric patients should be determined by a healthcare provider based on factors such as age, weight, and renal function.
3. Are there any side effects associated with Lerace Injection? Common side effects of Lerace Injection may include dizziness, drowsiness, fatigue, headache, and nausea. Serious side effects, such as hypersensitivity reactions, psychiatric symptoms, and hematologic abnormalities, may occur less frequently. It is essential to report any unusual or severe side effects to a healthcare provider promptly.
4. Can Lerace Injection be used during pregnancy or breastfeeding? The safety of Lerace Injection during pregnancy and breastfeeding has not been established conclusively. Pregnant or breastfeeding women should discuss the potential risks and benefits of Lerace Injection with a healthcare provider before starting treatment.
5. Can Lerace Injection be used as a single therapy for epilepsy? Lerace Injection is primarily used as adjunctive therapy in combination with other antiepileptic drugs for the management of seizures. However, in certain cases, Lerace Injection may be prescribed as monotherapy for epilepsy under the guidance of a healthcare provider.